Compare LEA & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEA | RGEN |
|---|---|---|
| Founded | 1917 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 6.6B |
| IPO Year | 1994 | 1995 |
| Metric | LEA | RGEN |
|---|---|---|
| Price | $131.32 | $138.13 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 12 |
| Target Price | $132.21 | ★ $167.67 |
| AVG Volume (30 Days) | 488.4K | ★ 749.1K |
| Earning Date | 05-01-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.39% | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | ★ 8.15 | 0.86 |
| Revenue | ★ $23,259,100,000.00 | $141,236,000.00 |
| Revenue This Year | $2.50 | $14.30 |
| Revenue Next Year | $3.12 | $14.52 |
| P/E Ratio | ★ $15.83 | $153.93 |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $81.62 | $109.66 |
| 52 Week High | $142.84 | $175.77 |
| Indicator | LEA | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 64.22 | 68.57 |
| Support Level | $115.26 | $111.29 |
| Resistance Level | $142.84 | $172.45 |
| Average True Range (ATR) | 3.05 | 4.89 |
| MACD | 1.17 | 2.60 |
| Stochastic Oscillator | 96.92 | 89.82 |
Lear Corp designs, develops, and manufactures automotive seating and electrical systems and components. The company has two reporting segments Seating and E-Systems. Seating components include frames and mechanisms, covers (leather and woven fabric), seat heating and cooling, foam, and headrests. Automotive electrical distribution and connection systems and electronic systems include wiring harnesses, terminals and connectors, on-board battery chargers, high-voltage battery management systems. The company earns majority of its revenue from the seating segment.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.